服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-PDCD1/CD279/PD1 mAbs [Eciskafusp Biosimilar] (MABL-4620) | MABL-4620 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TSLP mAbs [Ecleralimab Biosimilar] (MABL-4621) | MABL-4621 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CLDN1 mAbs [Eclutatug Biosimilar] (MABL-4622) | MABL-4622 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GD3 ganglioside mAbs [Ecromeximab Biosimilar] (MABL-4623) | MABL-4623 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Eculizumab Biosimilar] (MABL-4624) | MABL-4624 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-EPCAM/CD326 mAbs [Edrecolomab Biosimilar] (MABL-4625) | MABL-4625 | ELISA, FACS, Functional assay, in vivo binding | G2a, Kappa |
| Anti-ITGAL/CD11A/LFA1A mAbs [Efalizumab Biosimilar] (MABL-4626) | MABL-4626 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Heat Shock Protein 90 Homolog mAbs [Efungumab Biosimilar] (MABL-4627) | MABL-4627 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-KIT/CD117 mAbs [Eglatoprutug Biosimilar] (MABL-4628) | MABL-4628 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CXCL10/IP10 mAbs [Eldelumab Biosimilar] (MABL-4629) | MABL-4629 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TBC mAbs [Elegrobart Biosimilar] (MABL-4630) | MABL-4630 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-RGMA mAbs [Elezanumab Biosimilar] (MABL-4631) | MABL-4631 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-ERBB3/HER3 mAbs [Elgemtumab Biosimilar] (MABL-4632) | MABL-4632 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-APP mAbs [Donanemab Biosimilar] (MABL-4600) | MABL-4600 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Ganglioside GD2 mAbs [Donitabart Biosimilar] (MABL-4601) | MABL-4601 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL22;ALB mAbs [Donzakimig1 Biosimilar] (MABL-4602) | MABL-4602 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-IL13 mAbs [Donzakimig2 Biosimilar] (MABL-4603) | MABL-4603 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Dostarlimab Biosimilar] (MABL-4604) | MABL-4604 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL31 (Feline) mAbs [Dovanvetmab Biosimilar] (MABL-4605) | MABL-4605 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NT5E/CALJA/CD73 mAbs [Dresbuxelimab Biosimilar] (MABL-4606) | MABL-4606 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn